NM_032207.4:c.-45G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032207.4(C19orf44):​c.-45G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.853 in 450,926 control chromosomes in the GnomAD database, including 164,349 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.84 ( 53432 hom., cov: 31)
Exomes 𝑓: 0.86 ( 110917 hom. )

Consequence

C19orf44
NM_032207.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.155

Publications

12 publications found
Variant links:
Genes affected
C19orf44 (HGNC:26141): (chromosome 19 open reading frame 44)
C19orf44 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 19-16496422-G-C is Benign according to our data. Variant chr19-16496422-G-C is described in ClinVar as Benign. ClinVar VariationId is 1278372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032207.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C19orf44
NM_032207.4
MANE Select
c.-45G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9NP_115583.1Q9H6X5-1
C19orf44
NM_032207.4
MANE Select
c.-45G>C
5_prime_UTR
Exon 1 of 9NP_115583.1Q9H6X5-1
C19orf44
NM_001288834.2
c.-45G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 8NP_001275763.1M0R2B3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C19orf44
ENST00000221671.8
TSL:2 MANE Select
c.-45G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9ENSP00000221671.2Q9H6X5-1
C19orf44
ENST00000594035.5
TSL:1
c.-45G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 8ENSP00000472436.1M0R2B3
C19orf44
ENST00000221671.8
TSL:2 MANE Select
c.-45G>C
5_prime_UTR
Exon 1 of 9ENSP00000221671.2Q9H6X5-1

Frequencies

GnomAD3 genomes
AF:
0.837
AC:
127151
AN:
151958
Hom.:
53385
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.794
Gnomad AMI
AF:
0.883
Gnomad AMR
AF:
0.871
Gnomad ASJ
AF:
0.900
Gnomad EAS
AF:
0.695
Gnomad SAS
AF:
0.885
Gnomad FIN
AF:
0.770
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.868
Gnomad OTH
AF:
0.861
GnomAD4 exome
AF:
0.861
AC:
257190
AN:
298850
Hom.:
110917
Cov.:
2
AF XY:
0.863
AC XY:
136705
AN XY:
158394
show subpopulations
African (AFR)
AF:
0.791
AC:
7053
AN:
8912
American (AMR)
AF:
0.876
AC:
11037
AN:
12594
Ashkenazi Jewish (ASJ)
AF:
0.907
AC:
8100
AN:
8926
East Asian (EAS)
AF:
0.738
AC:
13021
AN:
17636
South Asian (SAS)
AF:
0.884
AC:
34247
AN:
38722
European-Finnish (FIN)
AF:
0.796
AC:
13610
AN:
17092
Middle Eastern (MID)
AF:
0.888
AC:
1085
AN:
1222
European-Non Finnish (NFE)
AF:
0.874
AC:
154536
AN:
176858
Other (OTH)
AF:
0.859
AC:
14501
AN:
16888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1703
3406
5108
6811
8514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
668
1336
2004
2672
3340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.837
AC:
127255
AN:
152076
Hom.:
53432
Cov.:
31
AF XY:
0.832
AC XY:
61855
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.794
AC:
32924
AN:
41480
American (AMR)
AF:
0.872
AC:
13312
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.900
AC:
3124
AN:
3472
East Asian (EAS)
AF:
0.695
AC:
3572
AN:
5136
South Asian (SAS)
AF:
0.886
AC:
4279
AN:
4830
European-Finnish (FIN)
AF:
0.770
AC:
8131
AN:
10562
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.868
AC:
59054
AN:
68012
Other (OTH)
AF:
0.857
AC:
1804
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1076
2152
3229
4305
5381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.829
Hom.:
2632
Bravo
AF:
0.838
Asia WGS
AF:
0.788
AC:
2740
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.1
DANN
Benign
0.49
PhyloP100
-0.15
PromoterAI
0.24
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs967886; hg19: chr19-16607233; API